The estimated Net Worth of Peggy V Phillips is at least $500 Thousand dollars as of 23 August 2021. Peggy Phillips owns over 4,166 units of Portola Pharmaceuticals stock worth over $500,026 and over the last 18 years Peggy sold PTLA stock worth over $0.
Sign up
Peggy Phillips PTLA stock SEC Form 4 insiders trading
Peggy has made over 3 trades of the Portola Pharmaceuticals stock since 2013, according to the Form 4 filled with the SEC. Most recently Peggy exercised 4,166 units of PTLA stock worth $18,747 on 23 August 2021.
The largest trade Peggy's ever made was buying 93,023 units of Portola Pharmaceuticals stock on 30 October 2013 worth over $100,465. On average, Peggy trades about 3,926 units every 98 days since 2006. As of 23 August 2021 Peggy still owns at least 27,733 units of Portola Pharmaceuticals stock.
You can see the complete history of Peggy Phillips stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Peggy Phillips's mailing address?
Peggy's mailing address filed with the SEC is C/O DYNAVAX TECHNOLOGIES, 2100 POWELL STREET, SUITE 720, EMERYVILLE, CA, 94608.
Insiders trading at Portola Pharmaceuticals
Over the last 16 years, insiders at Portola Pharmaceuticals have traded over $63,947,373 worth of Portola Pharmaceuticals stock and bought 4,311,442 units worth $137,660,828 . The most active insiders traders include (Mauritius) Pte Ltd Cairnhi..., James N Topper, and Jeffrey W Bird. On average, Portola Pharmaceuticals executives and independent directors trade stock every 43 days with the average trade being worth of $1,543,350. The most recent stock trade was executed by Hollings Renton on 1 November 2019, trading 5,000 units of PTLA stock currently worth $45,000.
What does Portola Pharmaceuticals do?
Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.
What does Portola Pharmaceuticals's logo look like?
Complete history of Peggy Phillips stock trades at Dynavax Technologies and Portola Pharmaceuticals
Portola Pharmaceuticals executives and stock owners
Portola Pharmaceuticals executives and other stock owners filed with the SEC include:
-
Ted W Love,
Director -
Ernie Meyer,
EVP and CHRO -
Henry Ward Wolff,
Director -
Hollings Renton,
Director -
Laura Brege,
Director -
William Lis,
Chief Executive Officer -
John Johnson,
Director -
(Mauritius) Pte Ltd Cairnhi...,
-
Jeffrey W Bird,
Director -
Charles J Homcy,
Director -
Management Pte Ltd Temasek ...,
-
David C Stump,
Director -
Dennis M Fenton,
Director -
Tao Fu,
EVP, CBO -
John B Moriarty,
EVP, General Counsel -
Rajiv Patni,
EVP, CMO -
John H Iii Lawrence,
SVP, Chief Medical Officer -
Glenn P Brame,
EVP, CTOO -
J. Scott Garland,
President and CEO -
John T Curnutte,
Executive Vice President -
Mardi Dier,
EVP and CFO -
Sheldon L. Koenig,
EVP, Chief Commercial Officer -
Robert Califf,
Director -
Farah Champsi,
Director -
(Mauritius) Pte Ltd Maxwell,
10% owner -
Nicholas Galakatos,
Director -
Jean Jacques Bienaime,
Director -
Russell C Hirsch,
Director -
Peggy V Phillips,
Director -
Jean George,
Director -
James N Topper,
Director